![Susan R. Rheingold, MD](/sites/default/files/styles/crop_and_center_300x375/public/providers-new-rheingold-sue.jpg?itok=LGlAhIog)
Susan R. Rheingold, MD
Areas of expertise: Adolescent and young adult care, Complementary medicine, De novo acute lymphoblastic leukemia, Developmental therapeutics, Leukemia, Hematologic malignancies, Hodgkin's lymphoma, Relapsed acute lymphoblastic leukemia, Non-Hodgkins lymphoma, Relapsed hematologic malignancies
About Susan R. Rheingold
Susan R. Rheingold, MD, is an attending physician, Department of Pediatrics, Division of Oncology, at The Children’s Hospital of Philadelphia and associate professor in Pediatrics at the University of Pennsylvania School of Medicine.
A 1992 graduate of the University of Pennsylvania School of Medicine, Dr. Rheingold completed a residency in pediatrics at John Hopkins Hospital in Baltimore, Maryland and a fellowship in Pediatric Hematology/Oncology at The Children’s Hospital of Philadelphia.
After completing her training in 1999, Dr. Rheingold joined the staff of Children’s Hospital. She currently serves as the Medical Director of the Oncology outpatient clinic and director of Oncology Education for the Division of Oncology.
Dr. Rheingold’s expertise is in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL). She serves on the Children’s Oncology Group’s Relapsed ALL Committee, Infant ALL Committee, and the Complementary Therapies Committee. Besides ALL, Dr. Rheingold maintains a special interest in experimental therapeutics and serves as a principal investigator for a Children’s Oncology Group national protocol.
Other interests include complementary and alternative therapies, supportive care for oncology patients undergoing chemotherapy, medical education and rare childhood tumors. Dr. Rheingold is board certified in Pediatrics as well as Pediatric Hematology/Oncology.
Titles
Medical Director, Oncology Outpatient Clinic
Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatric Hematology-Oncology – American Board of Pediatrics
Pediatrics – American Board of Pediatrics
Awards and Honors
2022, Philadelphia Magazine's Top Doctors in Pediatric Hematology-Oncology
2007, Leader of Family-Centered Care in Action, Voted by Staff and Families, CHOP
2005, 2007, 2008, 2010, 2013, Top Doctor, Philadelphia Magazine
2002, 2005, 2007, 2013, Faculty Honor Roll, Voted by Residents, CHOP
2002, Selected Participant, AAMC Early Career Women Faculty Professional Development Seminar
2001, Selected Participant, Federation of European Cancer Societies, AACR, ASCO, Methods in Clinical Cancer Research: Flims, Switzerland
1999, Young Investigator Award, American Society of Clinical Oncology: Control of B Lymphocyte Development by Pre-B Cell Receptor-Mediated Signaling
1998, Selected Participant, American Association for Cancer Research Workshop, Molecular Biology in Clinical Oncology: The Given Institute, Aspen, CO
1988, B.A. Magna Cum Laude, Dartmouth College, Hanover, NH
1988, Phi Beta Kappa, Dartmouth College, Hanover, NH
1986-1988, Green Key Society, Dartmouth College, Hanover, NH
1986-1988, Rufus Choate Scholar, Dartmouth College, Hanover, NH
Leadership and Memberships
Memberships in Professional Organizations
American Society of Clinical Oncology
American Society of Hematology
American Society of Pediatric Hematology/Oncology
Children’s Oncology Group
Editorial and Academic Positions
Editorial positions
Reviewer
British Journal of Hematology
Journal of Pediatrics
Journal of Pediatric Hematology/Oncology
Pediatric Blood & Cancer
Clinical Cancer Research
Academic and Institutional Committees
2013-present, Rapid Improvement Task Force, Center for Quality and Patient Safety
2008-present, Division of Oncology Pediatric Protocol Review Committee
2002-present, HIM Documentation Committee
2001-present, Admissions Committee, Perelman School of Medicine
Research Interests
Clinical research on relapsed leukemia Supportive Care Trials Experimental Drug Trials for ALL
Education & training
Medical Degree
MD - University of Pennsylvania School of Medicine, Philadelphia, PA
Internship
Pediatrics - Johns Hopkins Hospital, Baltimore MD
Residency
Pediatrics - Johns Hopkins Hospital, Baltimore MD
Fellowship
Pediatric Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA
Publications
Publications
2015
Johnson L, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN. Practical communication guidance to improve phase I informed consent conversations and end-of-life decision-making in pediatric oncology. Cancer, 2015; epub April.
2014
Shannon ML, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA. Chimeric antigen receptor T cells for sustained remissions in leukemia. New England Journal of Medicine, 2014;371(16):1507-17.
Plourde PV, Jeha S, Hijiya N, Keller FG, Silverman LB, Rheingold SR, Dreyer ZE, Dahl GV, Mercedes T, Lai C, Corn T. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial. Pediatr Blood Cancer, 2014; 61(7):1232-8.
Maude SL, Fitzgerald JC, Fisher BT, Li Y, Huang Y-S, Torp K, Seif AE, Kavcic M, Walker DM, Leckerman KH, Kilbaugh TJ, Rheingold SR, Sung L, Zaoutis TE, Berg RA, Nadkarni VM, Thomas NJ, Aplenc RA. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatric Critical Care Medicine, 2014 15(2):112-20.
Seif AE, Fisher BT, Li Y, Torp K, Rheam DP, Huang YV, Harris T, Shah A, Hall M, Fieldston E, Vujkovic M, Bailey C, Kersun LS, Reilly AF, Rheingold SR, Walker DS, Aplenc R. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer, 2014;61(5):846-52.
Sacks N, Hwang W-T, Lange BJ, Tan K-S, Sandler ES, Rogers PC, Womer RB, and Rheingold SR. Proactive enteral tube feeding in pediatric patients undergoing chemotherapy. Pediatr Blood Cancer, 2014; 61(2):281-5.
2013
Lothstein K, Fisher B, Li Y, Seif AE, Harris T, Torp K, Kavcic M, Huang YS, Rheingold SR, Aplenc R. Zoonotic infections in pediatric patients with acute leukemia. Pediatr Blood Cancer, 2013;60(12):E160-2.
Baker JN, Leek AC, Showalter Salas H, Gibson D, Drotar D, Noll R, Rheingold SR, Kodish ED. Suggestions from adolescent, young adult, and parents for improving informed consent in Phase I pediatric oncology trials. Cancer, 2013;60(5):873-8.
Teachey DT, Rheingold SR, Maude SL, Zugmaier G, Barrett DM, Seif AE, Nichols KE, Suppa EK, Kalos M, Aplenc KR, Gore L, and Grupp SA. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine directed therapy. Blood, 2013;121(26):5154-7.
Borst AJ, States LJ, Reilly AF, Rheingold SR. Determining response and recurrence in pediatric B-Cell lymphomas of the bone. Pediatr Blood Cancer, 2013;60(8):1281-6.
Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med, 2013; 368(16):1509-18.
Miller VA, Baker JN, Leek AC, Hizlan S, Rheingold, SR, Yamokoski AD, Drotar D, Kodish E. Adolescent perspectives on Phase I cancer research. Pediatr Blood Cancer, 2013;60(5):873-78.
Lectures by Invitation
2015
"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia”, MOC Session presenter- ASPHO, Phoenix, AZ, May 2015.
Federal Drug Administration Presenter and Panelist, “New Drugs: Breakthrough Therapies and Beyond”- AACR, Philadelphia, PA, April 2015.
2014
Session Moderator, “What’s all the Buzz about Targeted Immunotherapies for B-Cell Malignancies”- ASPHO, Chicago, IL, May 2014.
2013
“Pediatric ALL: Update on Treatment and Follow-up Care” - Leukemia & Lymphoma Society Telephone/Web Education Program, National Teleconference, November 2013.
“A Phase 1 Study of Temsirolimus in Combination with Etoposide & Cyclophosphamide in Children with Relapsed ALL and NHL” - Therapeutic Advances in Childhood Leukemia Annual Meeting, Chicago, IL, September 2013.
“The First Five ALL Patients Treated with Chimeric Antigen Receptor-Modified T-cells (CART)” - ALL Study Chair Affinity Group, International Teleconference, May 2013.
“Childhood Cancer” - Congreso Interamericano de Pediatria, Starmedica Conference, Mexico City, Mexico, January 2013.
Editorials, Reviews, Chapters
2015
Sacks N, Henry D, Rheingold SR. Oncology, Hematopoietic Transplant, Gastrointestinal Supportive Care Medications and Survivorship. In: A.S.P.E.N. Pediatric Nutrition Support Core Curriculum, 2nd Ed. M.A. Corkins ed. American Society for Parenteral and Enteral Nutrition, 2015
2013
Fisher M, Balamuth N, Rheingold SR. Basics Of Pediatric Anesthesia, In: Oncologic Diseases, 2nd Ed., RS Litman ed. Lippincott, Williams, and Wilkins, 2013
2012
Rheingold SR. The 5 Minute Pediatric Consult, 5th Ed. M.W. Schwartz ed. Williams & Wilkins. Leukocytosis , Acute Lymphoblastic Leukemia, 2012
2011
Green A, Rheingold SR. Leukemia. In: Netter’s Pediatrics, 1st Ed., T Florin and S Ludwig, eds. Elsevier Health Sciences, 2011
Fisher M, Rheingold SR. Oncologic Emergencies. In: Principles and Practice of Pediatric Oncology, 6th Ed. P.A. Pizzo and D.G. Poplack eds. Lippincott, Williams, and Wilkins, 2011
Wolfe L, Scerbo J, Rheingold SR. Management of Oncologic Emergencies. In: Manual of Pediatric Hematology and Oncology, 5th Ed., P. Lanzowsky ed. Elsevier Health Sciences, 2011.
2010
Rheingold SR. Oncologic emergencies. In: Davis DH, editor. Pediatric critical care: the requisites in pediatrics. Philadelphia: Elsevier Health Sciences-Mosby.
Bailey C, Felix C, Rheingold SR. Acute lymphoblastic leukemia. In: Brodeur GM, Manno CS, editors. Pediatric hematology/oncology: the requisites in pediatrics. Philadelphia: Elsevier-Mosby.
Teachey D, Bunin N, Rheingold SR. Germ cell tumors. In: Brodeur GM, Manno CS, editors. Pediatric hematology/oncology: the requisites in pediatrics. Philadelphia: Elsevier-Mosby.
Fisher M, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 2010.
Green A, Rheingold SR. Leukemia. In: Florin T, Ludwig S, editors. Netter's pediatrics. 1st ed. Philadelphia: Elsevier Health Sciences; 2010.
Wolfe L, Scerbo J, Rheingold SR. Management of oncologic emergencies. In: Lanzowsky P, editor. Manual of pediatric hematology and oncology. 5th ed. Philadelphia: Elsevier Health Sciences. 2010.
Sacks N, Wallace E, Bogucki B, Guzikowski V, Henry D, Rheingold SR. Hematology/oncology and hematopoietic transplant. In: Corkins M, editor. Pediatric nutrition support core curriculum. 1st ed. Silver Spring: American Society of Pediatric Enteral Nutrition (A.S.P.E.N.); 2010, p. 349.
2009
Rheingold SR, Neugut AI, Uldrick T, Meadows AT. Treatment-related secondary cancers. In: Hong WK, Bast RC, Hait WN, Kufe DW, Pollack RE, Weichselbaum RR, Holland JF, Frei EF, editors. Holland-Frei Cancer medicine. 8th ed. Shelton: People's Medical Publishing House; 2009. p. 1915.
2006
Rheingold SR, Neugut AI, Meadows AT. Treatment-related secondary cancers In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Hait W, Hong WK, Holland JF, Frei E, editors. Cancer medicine. 7th ed. Shelton: People's Medical Publishing House-USA; 2006.
2005
Rheingold SR, Lange BJ. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 1202-30.
Rheingold SR, Lange BJ. Oncologic emergencies. In: Fleisher GR, Ludwig S, editors. Textbook of pediatric emergency medicine. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 1239-74.